ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells

Triple-negative breast cancer (TNBC) is a heterogeneous group of estrogen, progesterone, and HER2-negative breast cancers with poor clinical outcomes. The imipridone ONC201 is a G-protein-coupled dopamine receptor D2 modulator and an allosteric agonist of the mitochondrial protease caseinolytic prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Bora, Peterson, Christine B., Davis, Alexander, Cho, Elin, Pearson, Troy, Liu, Huey, Hwang, Minha, Ueno, Naoto Tada, Lee, Jangsoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533320/
https://www.ncbi.nlm.nih.gov/pubmed/34680527
http://dx.doi.org/10.3390/biomedicines9101410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533320/
https://www.ncbi.nlm.nih.gov/pubmed/34680527
http://dx.doi.org/10.3390/biomedicines9101410

Ejemplares similares